 Graft Survival
"Graft Survival" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The survival of a graft in a host, the factors responsible for the survival and the changes occurring within the graft during growth in the host.
| Descriptor ID |
D006085
|
| MeSH Number(s) |
G12.425.901.545.340
|
| Concept/Terms |
Graft Survival- Graft Survival
- Graft Survivals
- Survival, Graft
- Survivals, Graft
|
Below are MeSH descriptors whose meaning is more general than "Graft Survival".
Below are MeSH descriptors whose meaning is more specific than "Graft Survival".
This graph shows the total number of publications written about "Graft Survival" by people in this website by year, and whether "Graft Survival" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1981 | 1 | 0 | 1 | | 1983 | 1 | 0 | 1 | | 1985 | 0 | 1 | 1 | | 1989 | 1 | 0 | 1 | | 1990 | 0 | 1 | 1 | | 1991 | 0 | 1 | 1 | | 1992 | 0 | 2 | 2 | | 1993 | 1 | 1 | 2 | | 1994 | 0 | 1 | 1 | | 1995 | 2 | 3 | 5 | | 1996 | 3 | 1 | 4 | | 1997 | 4 | 4 | 8 | | 1998 | 3 | 2 | 5 | | 1999 | 3 | 1 | 4 | | 2000 | 2 | 2 | 4 | | 2001 | 6 | 5 | 11 | | 2002 | 0 | 13 | 13 | | 2003 | 4 | 8 | 12 | | 2004 | 3 | 5 | 8 | | 2005 | 5 | 12 | 17 | | 2006 | 1 | 7 | 8 | | 2007 | 3 | 6 | 9 | | 2008 | 2 | 5 | 7 | | 2009 | 0 | 9 | 9 | | 2010 | 2 | 3 | 5 | | 2011 | 4 | 5 | 9 | | 2012 | 0 | 2 | 2 | | 2013 | 1 | 2 | 3 | | 2014 | 0 | 2 | 2 | | 2015 | 2 | 2 | 4 | | 2016 | 0 | 2 | 2 | | 2017 | 0 | 2 | 2 | | 2018 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Graft Survival" by people in Profiles.
-
Schwann TA, Gaudino M, Baldawi M, Tranbaugh R, Schwann AN, Habib RH. Optimal management of radial artery grafts in CABG: Patient and target vessel selection and anti-spasm therapy. J Card Surg. 2018 May; 33(5):205-212.
-
Borel F, Tang Q, Gernoux G, Greer C, Wang Z, Barzel A, Kay MA, Shultz LD, Greiner DL, Flotte TR, Brehm MA, Mueller C. Survival Advantage of Both Human Hepatocyte Xenografts and Genome-Edited Hepatocytes for Treatment of a-1 Antitrypsin Deficiency. Mol Ther. 2017 Nov 01; 25(11):2477-2489.
-
Chin MS, Chappell AG, Giatsidis G, Perry DJ, Lujan-Hernandez J, Haddad A, Matsumine H, Orgill DP, Lalikos JF. Hyperspectral Imaging Provides Early Prediction of Random Axial Flap Necrosis in a Preclinical Model. Plast Reconstr Surg. 2017 Jun; 139(6):1285e-1290e.
-
Mohiuddin MM, Singh AK, Corcoran PC, Thomas ML, Clark T, Lewis BG, Hoyt RF, Eckhaus M, Pierson RN, Belli AJ, Wolf E, Klymiuk N, Phelps C, Reimann KA, Ayares D, Horvath KA. Chimeric 2C10R4 anti-CD40 antibody therapy is critical for long-term survival of GTKO.hCD46.hTBM pig-to-primate cardiac xenograft. Nat Commun. 2016 Apr 05; 7:11138.
-
Orandi BJ, Luo X, Massie AB, Garonzik-Wang JM, Lonze BE, Ahmed R, Van Arendonk KJ, Stegall MD, Jordan SC, Oberholzer J, Dunn TB, Ratner LE, Kapur S, Pelletier RP, Roberts JP, Melcher ML, Singh P, Sudan DL, Posner MP, El-Amm JM, Shapiro R, Cooper M, Lipkowitz GS, Rees MA, Marsh CL, Sankari BR, Gerber DA, Nelson PW, Wellen J, Bozorgzadeh A, Gaber AO, Montgomery RA, Segev DL. Survival Benefit with Kidney Transplants from HLA-Incompatible Live Donors. N Engl J Med. 2016 Mar 10; 374(10):940-50.
-
Ascherman JA, Zeidler KR, Jacoby A, Appel JZ, Berkowitz RL, Castle J, Colwell A, Chun YS, Johnson DJ, Mohebali K. Carbon Dioxide versus Saline Tissue Expanders: Does It Matter? Plast Reconstr Surg. 2016 Jan; 137(1):31-5.
-
Lehman RE, Copeland LA, Stock EM, Fulcher SF. Graft Detachment Rate in DSEK/DSAEK After Same-Day Complete Air Removal. Cornea. 2015 Nov; 34(11):1358-61.
-
Hari P, Aljitawi OS, Arce-Lara C, Nath R, Callander N, Bhat G, Allen LF, Stockerl-Goldstein K. A Phase IIb, Multicenter, Open-Label, Safety, and Efficacy Study of High-Dose, Propylene Glycol-Free Melphalan Hydrochloride for Injection (EVOMELA) for Myeloablative Conditioning in Multiple Myeloma Patients Undergoing Autologous Transplantation. Biol Blood Marrow Transplant. 2015 Dec; 21(12):2100-5.
-
Chappell AG, Lujan-Hernandez J, Perry DJ, Corvera S, Lalikos JF. Alternatively Activated M2 Macrophages Improve Autologous Fat Graft Survival in a Mouse Model through Induction of Angiogenesis. Plast Reconstr Surg. 2015 Aug; 136(2):277e.
-
Lei J, Kim JI, Shi S, Zhang X, Machaidze Z, Lee S, Schuetz C, Martins PN, Oura T, Farkash EA, Rosales IA, Smith RN, Stott R, Lee KM, Soohoo J, Boskovic S, Cappetta K, Nadazdin OM, Yamada Y, Yeh H, Kawai T, Sachs DH, Benichou G, Markmann JF. Pilot Study Evaluating Regulatory T Cell-Promoting Immunosuppression and Nonimmunogenic Donor Antigen Delivery in a Nonhuman Primate Islet Allotransplantation Model. Am J Transplant. 2015 Oct; 15(10):2739-49.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|